<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16970804</article-id><article-id pub-id-type="pmc">1751043</article-id><article-id pub-id-type="publisher-id">cc5043</article-id><article-id pub-id-type="doi">10.1186/cc5043</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Intravenous nitroglycerin does not preserve gastric microcirculation during gastric tube reconstruction: a randomized controlled trial</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Buise</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>buisejan@xs4all.nl</email></contrib><contrib id="A2" contrib-type="author"><name><surname>van Bommel</surname><given-names>Jasper</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>jbommel@chello.nl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Jahn</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>alexanderjahn@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Tran</surname><given-names>Khe</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>c.tran@erasmusmc.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Tilanus</surname><given-names>Huug</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>h.w.tilanus@erasmusmc.nl</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Gommers</surname><given-names>Diederik</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>d.gommers@erasmusmc.nl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Anesthesiology, Erasmus MC Rotterdam, Gravendijkwal, 3015 CE Rotterdam, The Netherlands</aff><aff id="I2"><label>2</label>Department of Intensive Care, Erasmus MC Rotterdam, Gravendijkwal, 3015 CE Rotterdam, The Netherlands</aff><aff id="I3"><label>3</label>Department of Surgery, Erasmus MC Rotterdam, Gravendijkwal, 3015 CE Rotterdam, The Netherlands</aff><pub-date pub-type="ppub"><year>2006</year></pub-date><pub-date pub-type="epub"><day>13</day><month>9</month><year>2006</year></pub-date><volume>10</volume><issue>5</issue><fpage>R131</fpage><lpage>R131</lpage><ext-link ext-link-type="uri" xlink:href="http://ccforum.com/content/10/5/R131"></ext-link><history><date date-type="received"><day>26</day><month>6</month><year>2006</year></date><date date-type="rev-request"><day>17</day><month>7</month><year>2006</year></date><date date-type="rev-recd"><day>11</day><month>8</month><year>2006</year></date><date date-type="accepted"><day>13</day><month>9</month><year>2006</year></date></history><permissions><copyright-statement>Copyright © 2006 Buise et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Buise et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3978" xml_f="3990" txt_i="11" txt_f="23">Introduction</offsets></title><p><offsets xml_i="4001" xml_f="4555" txt_i="24" txt_f="578">Complications of oesophagectomy and gastric tube reconstruction include leakage and stenosis, which may be due to compromised microvascular blood flow (MBF) in gastric tissue. We recently demonstrated that decreased MBF could be improved perioperatively by topical administration of nitroglycerin. The aim of the present study was to investigate whether nitroglycerin, administered intravenously during gastric tube reconstruction, could preserve tissue blood flow and oxygenation in the gastric fundus, and reduce the incidence of postoperative leakage.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="4596" xml_f="4603" txt_i="580" txt_f="587">Methods</offsets></title><p><offsets xml_i="4614" xml_f="5128" txt_i="588" txt_f="1102">In this single-centre, prospective, double-blinded study, we randomized 32 patients scheduled for oesophagectomy into two groups. The intervention group received intravenous nitroglycerin during gastric tube reconstruction, and the control group received normal saline. Baseline values for MBF, microvascular haemoglobin oxygen saturation and microvascular haemoglobin concentration were determined at the gastric fundus before and after gastric tube construction and after pulling up the gastric tube to the neck.</offsets></p></sec><sec><title><offsets xml_i="5150" xml_f="5157" txt_i="1104" txt_f="1111">Results</offsets></title><p><offsets xml_i="5168" xml_f="5548" txt_i="1112" txt_f="1492">MBF and microvascular haemoglobin oxygen saturation decreased similarly in both groups during gastric tube reconstruction and were comparable. The oesophageal anastomosis was controlled by contrast radiography before discharge from the hospital; leakage was observed in two patients (13%) in the nitroglycerin group and five patients (31 %) in the control group (not significant).</offsets></p></sec><sec><title><offsets xml_i="5570" xml_f="5580" txt_i="1494" txt_f="1504">Conclusion</offsets></title><p><offsets xml_i="5591" xml_f="5878" txt_i="1505" txt_f="1792">Under stable systemic haemodynamic conditions, continuous intravenous administration of nitroglycerin could not prevent deterioration in gastric microvascular perfusion and microvascular haemoglobin saturation during gastric tube reconstruction. (Trial registration number NCT 00335010.)</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="5940" xml_f="5952" txt_i="1801" txt_f="1813">Introduction</offsets></title><p><offsets xml_i="5963" xml_f="6340" txt_i="1814" txt_f="2191">Oesophagectomy with direct reconstruction of the digestive tract remains the most successful therapy for oesophageal cancer. Frequent complications of the gastro-oesophageal anastomosis include leakage (5–26%) and anastomotic stenosis (12–40%), which have been attributed to decreased microvascular blood flow (MBF) and concomitant compromised oxygenation of the gastric tube [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6371" xml_f="6372" txt_i="2191" txt_f="2192">1</offsets></xref><offsets xml_i="6379" xml_f="6380" txt_i="2192" txt_f="2193">,</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6411" xml_f="6412" txt_i="2193" txt_f="2194">2</offsets></xref><offsets xml_i="6419" xml_f="6420" txt_i="2194" txt_f="2195">]</offsets></p><p><offsets xml_i="6427" xml_f="6709" txt_i="2196" txt_f="2478">The decrease in MBF is accounted for predominantly by diminished arterial supply of the gastric tube caused by ligation of several gastric arteries during the course of the procedure. On the other hand, venous congestion has been proposed to contribute to this reduced MBF as well [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6740" xml_f="6741" txt_i="2478" txt_f="2479">3</offsets></xref><offsets xml_i="6748" xml_f="6855" txt_i="2479" txt_f="2586">]. We recently demonstrated a decrease in MBF but not in microvascular haemoglobin oxygen saturation (μHbSO</offsets><sub><offsets xml_i="6860" xml_f="6861" txt_i="2586" txt_f="2587">2</offsets></sub><offsets xml_i="6867" xml_f="6952" txt_i="2587" txt_f="2672">) during gastric tube reconstruction, using simultaneous measurement of MBF and μHbSO</offsets><sub><offsets xml_i="6957" xml_f="6959" txt_i="2672" txt_f="2674">2 </offsets></sub><offsets xml_i="6965" xml_f="6966" txt_i="2674" txt_f="2675">[</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6997" xml_f="6998" txt_i="2675" txt_f="2676">4</offsets></xref><offsets xml_i="7005" xml_f="7104" txt_i="2676" txt_f="2775">]. We showed that the decreased MBF could be improved with topical administration of nitroglycerin.</offsets></p><p><offsets xml_i="7111" xml_f="7689" txt_i="2776" txt_f="3354">This effect of nitroglycerin, which must be considered temporary because of the short half-life of nitroglycerin, depends entirely on the accessibility of gastric tube tissue. Therefore, we considered this observation proof of principle, and hypothesized that it should be possible to establish a similar effect with intravenous administration of nitroglycerin. If so, then the effect could easily be prolonged during the days following surgery. Our hypothesis was supported by data reported by other investigators, who were able to improve tissue perfusion in septic patients [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7720" xml_f="7721" txt_i="3354" txt_f="3355">5</offsets></xref><offsets xml_i="7728" xml_f="7764" txt_i="3355" txt_f="3391">] or during cardiopulmonary bypass [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7795" xml_f="7796" txt_i="3391" txt_f="3392">6</offsets></xref><offsets xml_i="7803" xml_f="7980" txt_i="3392" txt_f="3569">] with intravenous administration of nitroglycerin. Based on these observations, we hypothesized that systemic administration of nitroglycerin can preserve gastric MBF and μHbSO</offsets><sub><offsets xml_i="7985" xml_f="7987" txt_i="3569" txt_f="3571">2 </offsets></sub><offsets xml_i="7993" xml_f="8028" txt_i="3571" txt_f="3606">during gastric tube reconstruction.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="8079" xml_f="8100" txt_i="3608" txt_f="3629">Materials and methods</offsets></title><p><offsets xml_i="8111" xml_f="8410" txt_i="3630" txt_f="3929">With the approval of the local institutional human investigation committee, and after obtaining written informed consent, 32 patients were included between May 2004 and March 2005. All patients were in physical status I and II, according to the American Society of Anesthesiologists classification [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="8441" xml_f="8442" txt_i="3929" txt_f="3930">7</offsets></xref><offsets xml_i="8449" xml_f="8451" txt_i="3930" txt_f="3932">].</offsets></p><p><offsets xml_i="8458" xml_f="9082" txt_i="3933" txt_f="4557">General anaesthesia was induced with propofol (1–2 mg/kg), sufentanil (0.1–0.3 μg/kg) and rocuroniumbromide (0.6 mg/kg). Anaesthesia was maintained with isoflurane (0.8–1.2 end-tidal %) in all patients. Before induction of general anaesthesia, a mid-thoracic epidural catheter was placed (between Th6 and Th8) to provide peroperative and postoperative analgesia. In all patients epidural blockade was started with a bolus of 10 ml bupivacaine 0.25%, before starting the operation. After 90 min, a mixture of bupivacaine 0.125% with fentanyl 2.5 μg/ml was administered through the epidural catheter at a dosage of 10 ml/hour.</offsets></p><p><offsets xml_i="9089" xml_f="9361" txt_i="4558" txt_f="4830">All patients were mechanically ventilated to achieve an arterial carbon dioxide tension of 4.5–5.5 kPa. Fractional inspired oxygen was initially set at 40%, but this was increased to 70% before fashioning the gastric tube. Positive end-expiratory pressure was set at 5 cmH</offsets><sub><offsets xml_i="9366" xml_f="9367" txt_i="4830" txt_f="4831">2</offsets></sub><offsets xml_i="9373" xml_f="9604" txt_i="4831" txt_f="5062">O. In all patients standard haemodynamic monitoring was used, including radial arterial blood pressure and right atrial pressure (RAP) measurements. Fluid management was performed using crystalloids and hydroxyethyl starch (Voluven</offsets><sup><offsets xml_i="9609" xml_f="9610" txt_i="5062" txt_f="5063">®</offsets></sup><offsets xml_i="9616" xml_f="10081" txt_i="5063" txt_f="5528">; Fresenius Kabi, 's-Hertogenbosch, The Netherlands) in order to maintain mean arterial pressure above 60 mmHg and RAP above 10 mmHg. The attending anaesthesiologists were advised to use vasopressors when the volume of colloids exceeded 2 l; the agent of choice was phenylephrin. Arterial and central venous oxygen and carbon dioxide partial pressures, haemoglobin concentration and haemoglobin saturation were determined (ABL 707; Radiometer, Copenhagen, Denmark).</offsets></p><sec><title><offsets xml_i="10097" xml_f="10116" txt_i="5529" txt_f="5548">Operation technique</offsets></title><p><offsets xml_i="10127" xml_f="11002" txt_i="5549" txt_f="6420">Two operation techniques were used: transhiatal and transthoracic oesophagectomy. Although these approaches differ, in both techniques the gastric tube is constructed in a similar manner by ligation of the left gastric artery, the right gastric artery, the short gastric arteries and the left gastroepiploic artery, and it is then fashioned along the greater curvature. As a consequence, the arterial supply of the upper part of the gastric tube depends exclusively on the right gastroepiploic arterial arcade. After transecting the oesophagus in the neck and stripping of the oesophagus, the gastric tube was pulled up via the prevertebral route where an oesophagogastrostomy was created. In all patients an end-to-side anastomosis was hand sewn with a single layer using absorbable monofilament suture (PDS 3–0, Ethicon; Johnson &amp; Johnson, Amersfoort, The Netherlands).</offsets></p><p><offsets xml_i="11009" xml_f="11077" txt_i="6421" txt_f="6489">All operations were performed by the same surgical team (KT and HT).</offsets></p></sec><sec><title><offsets xml_i="11099" xml_f="11155" txt_i="6491" txt_f="6547">Reflection spectrophotometry and laser Doppler flowmetry</offsets></title><p><offsets xml_i="11166" xml_f="11205" txt_i="6548" txt_f="6587">The microvascular parameters MBF, μHbSO</offsets><sub><offsets xml_i="11210" xml_f="11212" txt_i="6587" txt_f="6589">2 </offsets></sub><offsets xml_i="11218" xml_f="11315" txt_i="6589" txt_f="6686">and microvascular haemoglobin concentration (μHbcon) were determined simultaneously using the O2C</offsets><sup><offsets xml_i="11320" xml_f="11322" txt_i="6686" txt_f="6688">® </offsets></sup><offsets xml_i="11328" xml_f="11694" txt_i="6688" txt_f="7054">(Lea Medizin Technik, Giesen, Germany). This device combines two optical techniques, namely laser Doppler flowmetry (LDF) and reflectance spectrophotometry (RS), in one optic fibre. There is no interference between the two techniques because they operate at different light wave ranges. In the present study a flat probe was used, with a measurement depth of 4–6 mm.</offsets></p><p><offsets xml_i="11701" xml_f="11706" txt_i="7055" txt_f="7060">μHbSO</offsets><sub><offsets xml_i="11711" xml_f="11713" txt_i="7060" txt_f="7062">2 </offsets></sub><offsets xml_i="11719" xml_f="12293" txt_i="7062" txt_f="7636">was measured using RS. The tissue is illuminated with visible white light (500–630 nm), which is backscattered mainly by mitochondria and changed in colour by haemoglobin according to its oxygen saturation status. This reflected spectrum is detected and analyzed by a spectrophotometer with a frequency of more than 100 Hz; a mean of these values is provided every 2 s. In addition, the μHbcon is calculated as a relative value in arbitrary units (AU). The clinical usability of RS and its value for the assessment of microvascular oxygenation were demonstrated previously [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="12324" xml_f="12325" txt_i="7636" txt_f="7637">8</offsets></xref><offsets xml_i="12332" xml_f="12334" txt_i="7637" txt_f="7639">].</offsets></p><p><offsets xml_i="12341" xml_f="12489" txt_i="7640" txt_f="7788">LDF is a well established technique for the assessment of microvascular perfusion, and has been used frequently during gastric tube reconstruction [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="12520" xml_f="12521" txt_i="7788" txt_f="7789">3</offsets></xref><offsets xml_i="12528" xml_f="12529" txt_i="7789" txt_f="7790">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="12560" xml_f="12561" txt_i="7790" txt_f="7791">4</offsets></xref><offsets xml_i="12568" xml_f="12569" txt_i="7791" txt_f="7792">,</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="12600" xml_f="12601" txt_i="7792" txt_f="7793">9</offsets></xref><offsets xml_i="12608" xml_f="13118" txt_i="7793" txt_f="8303">]. Using LDF, MBF is determined by analysis of the power spectra from moving blood cells, generated by Doppler frequencies of backscattered laser light (820 nm). The MBF value is defined mathematically as the first moment of the Doppler power spectra, so it relates to the velocity of the erythrocytes multipled by the number of moving erythrocytes, and it is described in AU. Changes in MBF have been qualitatively related to the occurrence of intestinal tissue ischaemia. For instance, Pierie and coworkers [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="13149" xml_f="13150" txt_i="8303" txt_f="8304">9</offsets></xref><offsets xml_i="13157" xml_f="13458" txt_i="8304" txt_f="8605">] demonstrated that a reduction in gastric MBF of more than 70% from baseline values was a predictor of impaired healing of the cervical oesophagogastrostomy. Similarly, during intestinal hypotension a comparable decrease in jejunal mucosal perfusion was associated with increased lactate production [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="13490" xml_f="13492" txt_i="8605" txt_f="8607">10</offsets></xref><offsets xml_i="13499" xml_f="13501" txt_i="8607" txt_f="8609">].</offsets></p></sec><sec><title><offsets xml_i="13523" xml_f="13537" txt_i="8611" txt_f="8625">Study protocol</offsets></title><p><offsets xml_i="13548" xml_f="14066" txt_i="8626" txt_f="9144">Patients were randomized into two groups of 16 patients each. Randomization was performed by drawing of closed envelopes. The treatment group received intravenous nitroglycerin (Nitro Pohl; Transmedico BV, Weesp, The Netherlands) at a dosage of 1 μg/kg per min, started immediately following induction of anaesthesia. The control group received intravenous NaCl 0.9% at a similar infusion rate, started at the same time. The researcher and the attending anaesthesiologist were blinded as to the content of the syringe.</offsets></p><p><offsets xml_i="14073" xml_f="14194" txt_i="9145" txt_f="9266">After opening the abdomen, but before compromising the vascularization of the stomach, baseline values (T0) of MBF, μHbSO</offsets><sub><offsets xml_i="14199" xml_f="14201" txt_i="9266" txt_f="9268">2 </offsets></sub><offsets xml_i="14207" xml_f="14978" txt_i="9268" txt_f="10039">and μHbcon were collected. An average of measurements over 1 min (30 values) was obtained from two gastric areas; the pre-pyloric antrum and the fundus of the stomach where the future anastomosis of the gastric tube was expected. The probe was placed by the surgeon, gently touching the surface of the serosal side of the stomach. Pressure artifacts were identified by an obvious decrease in signal in both LDF and RS curves, and a change in configuration of the RS signal. After T0 the measurements were repeated two further times: after construction of the gastric tube (T1) and after pulling up the gastric tube to the neck (T2). Arterial and central venous blood gas analysis was performed simultaneously. At the end of the operation the study medication was stopped.</offsets></p><p><offsets xml_i="14985" xml_f="15192" txt_i="10040" txt_f="10247">As part of clinical practice following gastric tube reconstruction, all patients underwent a contrast radiography examination of the oesophagogastrostomy after at least 7 days or before leaving the hospital.</offsets></p></sec><sec><title><offsets xml_i="15214" xml_f="15234" txt_i="10249" txt_f="10269">Statistical analyses</offsets></title><p><offsets xml_i="15245" xml_f="15268" txt_i="10270" txt_f="10293">In our previous study [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="15299" xml_f="15300" txt_i="10293" txt_f="10294">4</offsets></xref><offsets xml_i="15307" xml_f="15499" txt_i="10294" txt_f="10486">], in which patient served as their own controls, we found a increase in MBF from 52 AU to 100 AU after application of nitroglycerin, with a standard deviation of 34.8 and 53.4, respectively [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="15530" xml_f="15531" txt_i="10486" txt_f="10487">4</offsets></xref><offsets xml_i="15538" xml_f="15683" txt_i="10487" txt_f="10632">]. A sample size of 16 in each group has 80% power to detect a difference between means of 45 with a significance level (α) of 0.05 (two-tailed).</offsets></p><p><offsets xml_i="15690" xml_f="15835" txt_i="10633" txt_f="10778">Values are reported as mean ± standard error. Each variable was analyzed using analysis of variance for repeated measurements. When appropriate, </offsets><italic><offsets xml_i="15843" xml_f="15852" txt_i="10778" txt_f="10787">post hoc </offsets></italic><offsets xml_i="15861" xml_f="16011" txt_i="10787" txt_f="10937">analyses were performed using the Bonferoni test. Differences between treatment and control groups at each time point were analyzed using an unpaired </offsets><italic><offsets xml_i="16019" xml_f="16020" txt_i="10937" txt_f="10938">t</offsets></italic><offsets xml_i="16029" xml_f="16122" txt_i="10938" txt_f="11031">-test. Incidences of postoperative leakage in the groups were compared using a Fischer test. </offsets><italic><offsets xml_i="16130" xml_f="16132" txt_i="11031" txt_f="11033">P </offsets></italic><offsets xml_i="16141" xml_f="16295" txt_i="11033" txt_f="11184">&lt; 0.05 was considered statistically significant. All analyses were performed using Graphpad Prism (version 3.0; Graphpad Software, San Diego, CA, USA).</offsets></p></sec></sec><sec><title><offsets xml_i="16323" xml_f="16330" txt_i="11187" txt_f="11194">Results</offsets></title><p><offsets xml_i="16341" xml_f="16407" txt_i="11195" txt_f="11261">Demographic and operation characteristics are summarized in Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="16439" xml_f="16440" txt_i="11261" txt_f="11262">1</offsets></xref><offsets xml_i="16447" xml_f="17223" txt_i="11262" txt_f="12038">. In the nitroglycerin group 15 people were operated on using the transhiatal approach as compared with 12 patients in the control group. There was a significant difference in fluid volume administration: 6.5 ± 1.3 l in the nitroglycerin group versus 7.7 ± 1.7 l in the control group. Total perioperative blood loss was similar in the two groups. Both groups received equal amounts of vasoactive medication. Mean arterial blood pressure was comparable throughout the procedure and did not change significantly in either group. Heart rate was higher in the nitroglycerin group during the entire operation than in the control group. RAP was significantly higher in the control group than in the nitroglycerin group at baseline, and decreased compared with baseline at T2 (Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="17255" xml_f="17256" txt_i="12038" txt_f="12039">2</offsets></xref><offsets xml_i="17263" xml_f="17265" txt_i="12039" txt_f="12041">).</offsets></p><p><offsets xml_i="17272" xml_f="17718" txt_i="12042" txt_f="12488">There was a significant difference in the central venous oxygen saturation between the control and the nitroglycerin groups at baseline. The arterial oxygen tension values were similar between groups throughout the procedure. There were significant differences in arterial haemoglobin concentration between baseline and subsequent time points in the two groups, and there was a difference in haemoglobin concentration between groups at T1 (Table </offsets><xref ref-type="table" rid="T3"><offsets xml_i="17750" xml_f="17751" txt_i="12488" txt_f="12489">3</offsets></xref><offsets xml_i="17758" xml_f="17760" txt_i="12489" txt_f="12491">).</offsets></p><p><offsets xml_i="17767" xml_f="17995" txt_i="12492" txt_f="12720">With respect to microvascular parameters, baseline values were similar in the two groups for all parameters at the gastric fundus and pylorus. There was no significant change in or difference between the two groups in MBF, μHbSO</offsets><sub><offsets xml_i="18000" xml_f="18002" txt_i="12720" txt_f="12722">2 </offsets></sub><offsets xml_i="18008" xml_f="18092" txt_i="12722" txt_f="12806">and μHbcon at the pyloric part of the stomach during the procedure (data not shown).</offsets></p><p><offsets xml_i="18099" xml_f="18124" txt_i="12807" txt_f="12832">As can be seen in Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="18154" xml_f="18155" txt_i="12832" txt_f="12833">1</offsets></xref><offsets xml_i="18162" xml_f="18440" txt_i="12833" txt_f="13111">, fundus MBF was 210 ± 17 AU in the nitroglycerin group and 216 ± 13 AU in the control group at baseline (not significant). There was a decrease at T1 in both the nitroglycerin group and the control group, but there was no further decrease from T1 to T2 in the two groups. μHbSO</offsets><sub><offsets xml_i="18445" xml_f="18447" txt_i="13111" txt_f="13113">2 </offsets></sub><offsets xml_i="18453" xml_f="18590" txt_i="13113" txt_f="13250">at T0 was 91 ± 2% in the nitroglycerin group and 86 ± 3% in the control group (not significant). There was no significant change in μHbSO</offsets><sub><offsets xml_i="18595" xml_f="18597" txt_i="13250" txt_f="13252">2 </offsets></sub><offsets xml_i="18603" xml_f="18661" txt_i="13252" txt_f="13310">in the two groups between T0 and T1. At T2, however, μHbSO</offsets><sub><offsets xml_i="18666" xml_f="18668" txt_i="13310" txt_f="13312">2 </offsets></sub><offsets xml_i="18674" xml_f="18991" txt_i="13312" txt_f="13629">decreased significantly in both groups, to 63 ± 5% in the nitroglycerin and 51 ± 7% in the control group. The μHbcon increased significantly between baseline and T1, from 72 ± 3 AU to 80 ± 3 AU in the nitroglycerin group and from 65 ± 3 AU to 78 ± 3 AU in the control group. There was no difference between T1 and T2.</offsets></p><p><offsets xml_i="18998" xml_f="19257" txt_i="13630" txt_f="13889">All patients underwent a contrast radiography examination of the oesophagogastrostomy. Two cases of anastomotic leakage occurred in the nitroglycerin group (12%) and five occurred in the control group (31%); this difference was not statistically significant (</offsets><italic><offsets xml_i="19265" xml_f="19267" txt_i="13889" txt_f="13891">P </offsets></italic><offsets xml_i="19276" xml_f="19362" txt_i="13891" txt_f="13977">= 0.19). We did not differentiate between minor or major, clinically relevant leakage.</offsets></p></sec><sec><title><offsets xml_i="19384" xml_f="19394" txt_i="13979" txt_f="13989">Discussion</offsets></title><p><offsets xml_i="19405" xml_f="19781" txt_i="13990" txt_f="14366">In the present study we were unable to prevent a decrease in gastric fundus microvascular perfusion and oxygenation during gastric tube reconstruction with continuous intravenous administration of nitroglycerin. This substance acts as a nitric oxide (NO) donor; in the vascular endothelium NO functions as a regulator of vascular tone, and thereby of microvascular perfusion [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="19813" xml_f="19815" txt_i="14366" txt_f="14368">11</offsets></xref><offsets xml_i="19822" xml_f="20009" txt_i="14368" txt_f="14555">]. NO plays an important role in the autoregulation of gastric mucosal blood flow, and it is likely that NO plays a role in protecting the gastric mucosa and preserves mucosal integrity [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="20041" xml_f="20043" txt_i="14555" txt_f="14557">12</offsets></xref><offsets xml_i="20050" xml_f="20051" txt_i="14557" txt_f="14558">,</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="20083" xml_f="20085" txt_i="14558" txt_f="14560">13</offsets></xref><offsets xml_i="20092" xml_f="20210" txt_i="14560" txt_f="14678">]. During conditions of decreased flow, use of nitroglycerin was shown to be effective in improving tissue perfusion [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="20241" xml_f="20242" txt_i="14678" txt_f="14679">4</offsets></xref><offsets xml_i="20249" xml_f="20250" txt_i="14679" txt_f="14680">-</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="20281" xml_f="20282" txt_i="14680" txt_f="14681">6</offsets></xref><offsets xml_i="20289" xml_f="20291" txt_i="14681" txt_f="14683">].</offsets></p><p><offsets xml_i="20298" xml_f="20389" txt_i="14684" txt_f="14775">Nevertheless, the present results are in contrast with the findings of our previous study [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="20420" xml_f="20421" txt_i="14775" txt_f="14776">4</offsets></xref><offsets xml_i="20428" xml_f="20851" txt_i="14776" txt_f="15199">], in which gastric MBF could be improved with application of nitroglycerin locally on the gastric tube tissue. It cannot be ruled out that the dose of nitroglycerin used in the present study might have been insufficient to establish effective tissue concentrations in the gastric tube. We opted for a dosage of 1 μg/kg per min, which was in the same range as that used in the studies of conducted by Spronk and coworkers [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="20882" xml_f="20883" txt_i="15199" txt_f="15200">5</offsets></xref><offsets xml_i="20890" xml_f="20957" txt_i="15200" txt_f="15267">] (0.5 mg bolus followed by 33.3 μg/min) and Iribe and colleagues [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="20988" xml_f="20989" txt_i="15267" txt_f="15268">6</offsets></xref><offsets xml_i="20996" xml_f="21119" txt_i="15268" txt_f="15391">] (0.5–2.0 μg/kg per min). In both studies tissue perfusion could be significantly improved with intravenous nitroglycerin.</offsets></p><p><offsets xml_i="21126" xml_f="21705" txt_i="15392" txt_f="15971">With topical administration, tissue concentrations must have been relatively high. If we had aimed to establish similar tissue concentrations or used an improvement in MBF as a therapeutic end-point, then greater amounts of nitroglycerin might have been required. On the other hand, during gastric tube reconstruction perfusion pressure (arterial blood pressure) is considered critical for adequate tissue perfusion and thus healing of the proximal anastomosis. Therefore, we decided not to use higher concentrations of nitroglycerin in our study to prevent its systemic effects.</offsets></p><p><offsets xml_i="21712" xml_f="22265" txt_i="15972" txt_f="16525">Haemodynamic stability is demonstrated by the unchanged mean arterial pressure and RAP during the entire study protocol in the nitroglycerin group. There was a difference in the central venous haemoglobin oxygen saturation between the nitroglycerin and NaCl groups at T0, but this was not related to a difference in microvascular saturation. We did not measure cardiac output because we believe that there is no relation between changes in cardiac output and changes in microvascular blood flow, as was recently demonstrated by De Backer and coworkers [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="22297" xml_f="22299" txt_i="16525" txt_f="16527">14</offsets></xref><offsets xml_i="22306" xml_f="22308" txt_i="16527" txt_f="16529">].</offsets></p><p><offsets xml_i="22315" xml_f="23169" txt_i="16530" txt_f="17384">Although one might assume that systemic circulatory capacitance is increased by nitroglycerin, the experimental group received less fluid during the procedure. Several reasons can have contributed to this finding. One is that in this study hypotension was primarily treated with fluid instead of vasopressors. As a result, too much fluid was administered in both groups with regard to the end-points for fluid administration. Looking at RAP, it can be seen that in all patients RAP was well above 10 mmHg during the entire procedure. If we had adhered to these end-points more strictly, then less fluid might have been administered, certainly in the control group, and differences in venous capacitance between the two groups might have been more marked. In the experimental conditions employed, only at baseline was RAP lower in the nitroglycerin group.</offsets></p><p><offsets xml_i="23176" xml_f="23570" txt_i="17385" txt_f="17779">Another reason is that we cannot rule out the possibility that the dosage of nitroglycerin was simply too low to cause an effect on systemic circulatory capacitance, and therefore did not lead to increased administration of fluids in the experimental group. Whether a higher dose of nitroglycerin in combination with more fluids would have an effect on the microcirculation remains speculative.</offsets></p><p><offsets xml_i="23577" xml_f="24125" txt_i="17780" txt_f="18328">Despite the differences in fluid administration, haemoglobin concentrations in the two groups were in the same range throughout the study period. Based on the American Society of Anesthesiologists guidelines for blood transfusion, a permissive anaemia strategy was used. Acute anaemia in the absence of hypovolaemia is known to have an effect on tissue perfusion. Microvascular perfusion is augmented by an increase in the amount of perfused capillaries in the tissue (capillary recruitment) and by vasodilatation of microvessels already perfused [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="24157" xml_f="24159" txt_i="18328" txt_f="18330">15</offsets></xref><offsets xml_i="24166" xml_f="24167" txt_i="18330" txt_f="18331">-</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="24199" xml_f="24201" txt_i="18331" txt_f="18333">17</offsets></xref><offsets xml_i="24208" xml_f="24388" txt_i="18333" txt_f="18513">]. As a result, the absolute amount of oxygen transported by the capillaries can be maintained. In the splanchnic tissues, NO is thought to play an important role in this process [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="24420" xml_f="24422" txt_i="18513" txt_f="18515">18</offsets></xref><offsets xml_i="24429" xml_f="24430" txt_i="18515" txt_f="18516">,</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="24462" xml_f="24464" txt_i="18516" txt_f="18518">19</offsets></xref><offsets xml_i="24471" xml_f="24744" txt_i="18518" txt_f="18791">]. It can be hypothesized that, under these circumstances, administration of an NO donor such as nitroglycerin might not have as much an effect as when thre are higher haemoglobin levels. This mechanism might have interfered with the effect of nitroglycerin administration.</offsets></p><p><offsets xml_i="24751" xml_f="24839" txt_i="18792" txt_f="18880">The simultaneous decrease in MBF and increase in μHbcon, followed by a decrease in μHbSO</offsets><sub><offsets xml_i="24844" xml_f="24846" txt_i="18880" txt_f="18882">2 </offsets></sub><offsets xml_i="24852" xml_f="25057" txt_i="18882" txt_f="19087">at a later stage, implies that venous congestion plays an important role in the decrease in gastric tissue perfusion during gastric tube reconstruction. This mechanism has been proposed by others as well [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="25088" xml_f="25089" txt_i="19087" txt_f="19088">3</offsets></xref><offsets xml_i="25096" xml_f="25424" txt_i="19088" txt_f="19416">]. Blood flow in the mucosal and serosal layers of the gut is known to behave differently under certain circumstances. In addition, the distinct effects of NO donors such as nitroglycerin on the various layers of the gastric tissue during this kind of surgery are unknown. For obvious reasons, we were only able to apply the O2C</offsets><sup><offsets xml_i="25429" xml_f="25431" txt_i="19416" txt_f="19418">® </offsets></sup><offsets xml_i="25437" xml_f="25743" txt_i="19418" txt_f="19724">probe on the serosal side of the gastric tube. Because the measurement depth of this probe is in the 4–6 mm range, we cannot distinguish between the different layers of the gastric tissue. It is therefore very difficult to draw any conclusions regarding differential tissue blood flow changes in our study.</offsets></p><p><offsets xml_i="25750" xml_f="26269" txt_i="19725" txt_f="20244">Finally, the incidence of anastomotic leakage is relatively high in the total study population (22%); this included clinically relevant leakage as well as leakage restricted to radiological signs only. Although not supported by the microvascular data, we observed a tendency toward a lower incidence of anastomotic leakage in the nitroglycerin group. This result did not achieve statistical significance, but the study was not designed for that purpose either. Larger patient numbers might be required to evaluate this.</offsets></p></sec><sec><title><offsets xml_i="26291" xml_f="26301" txt_i="20246" txt_f="20256">Conclusion</offsets></title><p><offsets xml_i="26312" xml_f="26441" txt_i="20257" txt_f="20386">Intravenous administration of nitroglycerin at a dosage of 1 μg/kg per min does not prevent the decrease in gastric MBF and μHbSO</offsets><sub><offsets xml_i="26446" xml_f="26448" txt_i="20386" txt_f="20388">2 </offsets></sub><offsets xml_i="26454" xml_f="26738" txt_i="20388" txt_f="20672">that occur following gastric tube reconstruction. Further research is necessary to gain more insight into the effect of NO donors on impaired microvascular perfusion and oxygenation in general, and its relation to anastomotic complications following oesophagogastrostomy specifically.</offsets></p></sec><sec><title><offsets xml_i="26760" xml_f="26772" txt_i="20674" txt_f="20686">Key messages</offsets></title><p><offsets xml_i="26783" xml_f="26922" txt_i="20687" txt_f="20826">• Venous congestion plays an important role in the impairment in microvascular perfusion that occurs following gastric tube reconstruction.</offsets></p><p><offsets xml_i="26929" xml_f="27084" txt_i="20827" txt_f="20982">• Intravenous nitroglycerin at a rate of 1 μg/kg per min does not prevent the deterioration in gastric microcirculation during gastric tube reconstruction.</offsets></p></sec><sec><title><offsets xml_i="27106" xml_f="27119" txt_i="20984" txt_f="20997">Abbreviations</offsets></title><p><offsets xml_i="27130" xml_f="27207" txt_i="20998" txt_f="21075">AU = arbitrary units; μHbcon = microvascular haemoglobin concentration; μHbSO</offsets><sub><offsets xml_i="27212" xml_f="27214" txt_i="21075" txt_f="21077">2 </offsets></sub><offsets xml_i="27220" xml_f="27413" txt_i="21077" txt_f="21270">= microvascular haemoglobin oxygen saturation; LDF = laser Doppler flowmetry; MBF = microvascular blood flow; NO = nitric oxide; RAP = right atrial pressure; RS = reflectance spectrophotometry.</offsets></p></sec><sec><title><offsets xml_i="27435" xml_f="27454" txt_i="21272" txt_f="21291">Competing interests</offsets></title><p><offsets xml_i="27465" xml_f="27523" txt_i="21292" txt_f="21350">The authors declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="27545" xml_f="27567" txt_i="21352" txt_f="21374">Authors' contributions</offsets></title><p><offsets xml_i="27578" xml_f="27965" txt_i="21375" txt_f="21762">MB was the principal investigator. JVB acted as study monitor, assisted in the data analysis and helped to draft the manuscript. AJ performed data collection. KT and HT performed surgery and measurements, and participated in data interpretation. DG participated in the study design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.</offsets></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierie</surname><given-names>JP</given-names></name><name><surname>Graaf de</surname><given-names>PW</given-names></name><name><surname>Poen</surname><given-names>H</given-names></name><name><surname>van der Tweel</surname><given-names>I</given-names></name><name><surname>Obertop</surname><given-names>H</given-names></name></person-group><article-title>Incidence and management of benign anastomotic stricture after cervical oesophagogastrostomy</article-title><source>Br J Surg</source><year>1993</year><volume>80</volume><fpage>471</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">8495314</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacobi</surname><given-names>CA</given-names></name><name><surname>Zieren</surname><given-names>HU</given-names></name><name><surname>Muller</surname><given-names>JM</given-names></name><name><surname>Adili</surname><given-names>F</given-names></name><name><surname>Pichlmaier</surname><given-names>H</given-names></name></person-group><article-title>Anastomotic tissue oxygen tension during esophagectomy in patients with esophageal carcinoma</article-title><source>Eur Surg Res</source><year>1996</year><volume>28</volume><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8682141</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Sugiyama</surname><given-names>A</given-names></name><name><surname>Ikegama</surname><given-names>T</given-names></name><name><surname>Ishida</surname><given-names>K</given-names></name><name><surname>Maruta</surname><given-names>F</given-names></name><name><surname>Shimizu</surname><given-names>F</given-names></name><name><surname>Ikeno</surname><given-names>T</given-names></name><name><surname>Kawasaki</surname><given-names>S</given-names></name></person-group><article-title>Revascularization using the short gastric vessels of the gastric tube after subtotal esophagectomy for intrathoracic esophageal carcinoma</article-title><source>J Am Coll Surg</source><year>2000</year><volume>190</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">10625235</pub-id><pub-id pub-id-type="doi">10.1016/S1072-7515(99)00234-3</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buise</surname><given-names>MP</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Tilanus</surname><given-names>HW</given-names></name><name><surname>Klein</surname><given-names>J</given-names></name><name><surname>Gommers</surname><given-names>D</given-names></name><name><surname>Van Bommel</surname><given-names>J</given-names></name></person-group><article-title>The effect of nitroglycerin on microvascular perfusion and oxygenation during gastric tube reconstruction</article-title><source>Anesth Analg</source><year>2005</year><volume>100</volume><fpage>1107</fpage><lpage>1111</lpage><pub-id pub-id-type="pmid">15781529</pub-id><pub-id pub-id-type="doi">10.1213/01.ANE.0000147665.60613.CA</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spronk</surname><given-names>PE</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Gardien</surname><given-names>MJ</given-names></name><name><surname>Mathura</surname><given-names>KR</given-names></name><name><surname>Oudemans-van Straaten</surname><given-names>HM</given-names></name><name><surname>Zandstra</surname><given-names>DF</given-names></name></person-group><article-title>Nitroglycerin in septic shock after intravascular volume resuscitation</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>1395</fpage><lpage>1396</lpage><pub-id pub-id-type="pmid">12423989</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11393-6</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iribe</surname><given-names>G</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Hayaschi</surname><given-names>Y</given-names></name><name><surname>Kuro</surname><given-names>M</given-names></name></person-group><article-title>Effect of prostaglandin E<sub>1 </sub>and nitroglycerin on portal venous flow during hypothermic extracorporeal circulation: assessment by transesophageal echography</article-title><source>Acta Anaesthesiol Scand</source><year>1999</year><volume>43</volume><fpage>520</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">10341999</pub-id><pub-id pub-id-type="doi">10.1034/j.1399-6576.1999.430506.x</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><collab>American Society of Anesthesiologists</collab></person-group><article-title>New classification of physical status</article-title><source>Anesthesiology</source><year>1963</year><volume>24</volume><fpage>111</fpage></citation></ref><ref id="B8"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Buise</surname><given-names>M</given-names></name><name><surname>Van Bommel</surname><given-names>J</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><person-group person-group-type="editor"><name><surname>JL Vincent. Berlin</surname></name></person-group><article-title>Reflectance spectrophotometry and tissue oxygenation in experimental and clinical practice</article-title><source>Yearbook of Intensive Care and Emergency Medicine</source><year>2003</year><publisher-name>Heidelberg: Springer Verlag</publisher-name><fpage>553</fpage><lpage>563</lpage></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierie</surname><given-names>JP</given-names></name><name><surname>de Graaf</surname><given-names>PW</given-names></name><name><surname>Poen</surname><given-names>H</given-names></name><name><surname>Van der Tweel</surname><given-names>I</given-names></name><name><surname>Obertop</surname><given-names>H</given-names></name></person-group><article-title>Impaired healing of cervical gastric oesophagogastrostomies can be predicted by estimation of gastric serosal blood perfusion by laser Doppler flowmetry</article-title><source>Eur J Surg</source><year>1994</year><volume>160</volume><fpage>599</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">7858044</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fröjse</surname><given-names>R</given-names></name><name><surname>Lehtipalo</surname><given-names>S</given-names></name><name><surname>Bergstrand</surname><given-names>U</given-names></name><name><surname>Biber</surname><given-names>B</given-names></name><name><surname>Winsö</surname><given-names>O</given-names></name><name><surname>Johansson</surname><given-names>G</given-names></name><name><surname>Arnerlöv</surname><given-names>C</given-names></name></person-group><article-title>Local metabolic effects of dopexamine on the intestine during mesenteric hypoperfusion</article-title><source>Shock</source><year>2004</year><volume>21</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">14770037</pub-id><pub-id pub-id-type="doi">10.1097/01.shk.0000111826.07309.8b</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buwalda</surname><given-names>M</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Opening the microcirculation: can vasodilators be useful in sepsis?</article-title><source>Intensive Care Med</source><year>2002</year><volume>28</volume><fpage>1208</fpage><lpage>1217</lpage><pub-id pub-id-type="pmid">12209267</pub-id><pub-id pub-id-type="doi">10.1007/s00134-002-1407-2</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pique</surname><given-names>JM</given-names></name><name><surname>Whittle</surname><given-names>BJ</given-names></name><name><surname>Esplugues</surname><given-names>JV</given-names></name></person-group><article-title>The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation</article-title><source>Eur J Pharmacol</source><year>1989</year><volume>174</volume><fpage>293</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">2630303</pub-id><pub-id pub-id-type="doi">10.1016/0014-2999(89)90324-5</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittle</surname><given-names>B</given-names></name><name><surname>Lopez-Belmonte</surname><given-names>J</given-names></name><name><surname>Moncada</surname><given-names>S</given-names></name></person-group><article-title>Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat</article-title><source>Br J Pharmacol</source><year>1990</year><volume>99</volume><fpage>607</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">2110019</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Dubois</surname><given-names>MJ</given-names></name><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Verdant</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>403</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">16424721</pub-id><pub-id pub-id-type="doi">10.1097/01.CCM.0000198107.61493.5A</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JL</given-names></name><name><surname>Duvelleroy</surname><given-names>M</given-names></name><name><surname>Teisseire</surname><given-names>B</given-names></name><name><surname>Duruble</surname><given-names>M</given-names></name></person-group><article-title>Effect of an increase in HbO2 affinity on the calculated capillary recruitment of an isolated rat heart</article-title><source>Pflügers Arch</source><year>1979</year><volume>382</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/BF00585904</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>PS</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Eckel</surname><given-names>PK</given-names></name><name><surname>Chavez</surname><given-names>R</given-names></name><name><surname>Ismail</surname><given-names>EF</given-names></name><name><surname>Gould</surname><given-names>SA</given-names></name><name><surname>Ramez Salem</surname><given-names>M</given-names></name><name><surname>Crystal</surname><given-names>GJ</given-names></name></person-group><article-title>Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis</article-title><source>Am J Physiol</source><year>1993</year><volume>265</volume><fpage>H340</fpage><lpage>H349</lpage><pub-id pub-id-type="pmid">8342651</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Bommel</surname><given-names>J</given-names></name><name><surname>Siegemund</surname><given-names>M</given-names></name><name><surname>Henny</surname><given-names>CP</given-names></name><name><surname>Trouwborst</surname><given-names>A</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Critical hematocrit in intestinal tissue oxygenation during severe normovolemic hemodilution</article-title><source>Anesthesiology</source><year>2001</year><volume>94</volume><fpage>152</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">11135735</pub-id><pub-id pub-id-type="doi">10.1097/00000542-200101000-00026</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doss</surname><given-names>DN</given-names></name><name><surname>Estefanous</surname><given-names>FG</given-names></name><name><surname>Ferrario</surname><given-names>CM</given-names></name><name><surname>Brum</surname><given-names>JM</given-names></name><name><surname>Murray</surname><given-names>PA</given-names></name></person-group><article-title>Mechanism of systemic vasodilation during normovolemic hemodilution</article-title><source>Anesth Analg</source><year>1995</year><volume>81</volume><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">7541185</pub-id><pub-id pub-id-type="doi">10.1097/00000539-199507000-00006</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Panes</surname><given-names>J</given-names></name><name><surname>Casadevall</surname><given-names>M</given-names></name><name><surname>Pique</surname><given-names>JM</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name><name><surname>Whittle</surname><given-names>BJ</given-names></name><name><surname>Teres</surname><given-names>J</given-names></name></person-group><article-title>Effects of acute normovolemic anemia on gastric mucosal blood flow in rats: role of nitric oxide</article-title><source>Gastroenterology</source><year>1992</year><volume>103</volume><fpage>407</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">1634059</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Microvascular parameters. MBF, μHbSO<sub>2 </sub>and μHbcon measured at the fundus of the stomach during gastric tube reconstruction. The MBF decreased between T0 and T1 and the μHbSO<sub>2 </sub>decreased between T1 and T2. Values are expressed as mean ± standard error. *<italic>P </italic>&lt; 0.05 versus baseline (T0). μHbcon, microvascular haemoglobin concentration; μHbSO<sub>2</sub>, microvascular haemoglobin oxygen saturation; MBF, microvascular blood flow; T0, baseline; T1, after construction of the gastric tube; T2, after pulling up the gastric tube to the neck.</p></caption><graphic xlink:href="cc5043-1"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Demographic and operative characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Characteristic</td><td align="center" colspan="2">Group</td></tr><tr><td></td><td align="left">Nitroglycerin</td><td align="left">NaCl (control)</td></tr></thead><tbody><tr><td align="left">Male/female (<italic>n</italic>)</td><td align="left">14/2</td><td align="left">13/3</td></tr><tr><td align="left">Age (years)</td><td align="left">62 ± 11</td><td align="left">61 ± 9</td></tr><tr><td align="left">Operation time (min)</td><td align="left">236 ± 52</td><td align="left">245 ± 55</td></tr><tr><td align="left">Infusion (l)</td><td align="left">6.5 ± 1.3*</td><td align="left">7.7 ± 1.7</td></tr><tr><td align="left">Blood loss (l)</td><td align="left">1.1 ± 0.1</td><td align="left">1.4 ± 0.2</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± standard error. *<italic>P </italic>&lt; 0.05 NaCl (control) versus nitroglycerin.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Haemodynamic parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Parameter</td><td align="left">Group</td><td align="center" colspan="3">Time point</td></tr><tr><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td></td><td align="left">T0</td><td align="left">T1</td><td align="left">T2</td></tr></thead><tbody><tr><td align="left">MAP (mmHg)</td><td align="left">NTG</td><td align="left">70 ± 2</td><td align="left">72 ± 3</td><td align="left">70 ± 2</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">75 ± 4</td><td align="left">73 ± 3</td><td align="left">72 ± 2</td></tr><tr><td align="left">RAP (mmHg)</td><td align="left">NTG</td><td align="left">13 ± 1*</td><td align="left">12 ± 1</td><td align="left">11 ± 1</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">16 ± 1</td><td align="left">14 ± 1</td><td align="left">13 ± 1**</td></tr><tr><td align="left">HR (beats/min)</td><td align="left">NTG</td><td align="left">86 ± 3*</td><td align="left">83 ± 3*</td><td align="left">88 ± 3*</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">74 ± 3</td><td align="left">71 ± 3</td><td align="left">75 ± 4</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± standard error. *<italic>P </italic>&lt; 0.05 NTG versus NaCl (control); **<italic>P </italic>&lt; 0.05 versus T0 (baseline). HR, heart rate; MAP, mean arterial pressure; NaCl, normal saline (control); NTG, nitroglycerin; RAP, right atrial pressure; T0, baseline; T1, after construction of the gastric tube; T2, after pulling up the gastric tube to the neck.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Blood gas analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Parameter</td><td align="left">Group</td><td align="center" colspan="3">Time point</td></tr><tr><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td></td><td align="left">T0</td><td align="left">T1</td><td align="left">T2</td></tr></thead><tbody><tr><td align="left">SaO<sub>2 </sub>(%)</td><td align="left">NTG</td><td align="left">99 ± 0</td><td align="left">99 ± 0</td><td align="left">99 ± 0</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">99 ± 0</td><td align="left">99 ± 0</td><td align="left">99 ± 0</td></tr><tr><td align="left">ScvO<sub>2 </sub>(%)</td><td align="left">NTG</td><td align="left">88 ± 0</td><td align="left">86 ± 0</td><td align="left">89 ± 0</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">83 ± 0*</td><td align="left">85 ± 0</td><td align="left">87 ± 0</td></tr><tr><td align="left">PaO<sub>2 </sub>(kPa)</td><td align="left">NTG</td><td align="left">23 ± 2</td><td align="left">32 ± 2**</td><td align="left">37 ± 5**</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">23 ± 2</td><td align="left">34 ± 3**</td><td align="left">36 ± 3**</td></tr><tr><td align="left">Hb (mmol/l)</td><td align="left">NTG</td><td align="left">6.2 ± 0.3</td><td align="left">5.6 ± 0.2**</td><td align="left">6.0 ± 0.2</td></tr><tr><td></td><td align="left">NaCl</td><td align="left">6.4 ± 0.7</td><td align="left">6.3 ± 0.5*</td><td align="left">5.9 ± 0.8**</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean ± standard error. Hb, haemoglobin; NaCl, normal saline (control); NTG, nitroglycerin; PaO<sub>2</sub>, arterial oxygen tension; SaO<sub>2</sub>, arterial haemoglobin oxygen saturation; ScvO<sub>2</sub>, central venous haemoglobin oxygen saturation; T0, baseline; T1, after construction of the gastric tube; T2, after pulling up the gastric tube to the neck. *<italic>P </italic>&lt; 0.05 NTG versus NaCl (control); **<italic>P </italic>&lt; 0.05 versus T0 (baseline).</p></table-wrap-foot></table-wrap></sec></back></article>